Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 3
1965 35
1966 60
1967 44
1968 34
1969 17
1970 15
1971 17
1972 21
1973 20
1974 9
1975 8
1976 11
1977 22
1978 13
1979 5
1980 6
1981 12
1982 4
1983 8
1984 9
1985 16
1986 9
1987 5
1988 15
1989 6
1990 16
1991 11
1992 13
1993 9
1994 24
1995 20
1996 23
1997 29
1998 29
1999 45
2000 46
2001 66
2002 95
2003 98
2004 81
2005 75
2006 102
2007 86
2008 89
2009 97
2010 71
2011 66
2012 79
2013 59
2014 49
2015 55
2016 55
2017 46
2018 48
2019 51
2020 48
2021 43
2022 30
2023 25
2024 36

Text availability

Article attribute

Article type

Publication date

Search Results

2,095 results

Results by year

Filters applied: . Clear all
Page 1
Thalidomide-induced teratogenesis: history and mechanisms.
Vargesson N. Vargesson N. Birth Defects Res C Embryo Today. 2015 Jun;105(2):140-56. doi: 10.1002/bdrc.21096. Epub 2015 Jun 4. Birth Defects Res C Embryo Today. 2015. PMID: 26043938 Free PMC article. Review.
Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia.
Chen H, Wu S, Tang M, Zhao R, Zhang Q, Dai Z, Gao Y, Yang S, Li Z, Du Y, Yang A, Zhong L, Lu L, Xu L, Shen X, Liu S, Zhong J, Li X, Lu H, Xiong H, Shen Y, Chen H, Gong S, Xue H, Ge Z. Chen H, et al. N Engl J Med. 2023 Nov 2;389(18):1649-1659. doi: 10.1056/NEJMoa2303706. N Engl J Med. 2023. PMID: 37913505 Clinical Trial.
Plasticity in binding confers selectivity in ligand-induced protein degradation.
Nowak RP, DeAngelo SL, Buckley D, He Z, Donovan KA, An J, Safaee N, Jedrychowski MP, Ponthier CM, Ishoey M, Zhang T, Mancias JD, Gray NS, Bradner JE, Fischer ES. Nowak RP, et al. Nat Chem Biol. 2018 Jul;14(7):706-714. doi: 10.1038/s41589-018-0055-y. Epub 2018 Jun 11. Nat Chem Biol. 2018. PMID: 29892083 Free PMC article.
Thalidomide and neurotrophism.
Soper JR, Bonar SF, O'Sullivan DJ, McCredie J, Willert HG. Soper JR, et al. Skeletal Radiol. 2019 Apr;48(4):517-525. doi: 10.1007/s00256-018-3086-2. Epub 2018 Oct 19. Skeletal Radiol. 2019. PMID: 30341712 Free PMC article. Review.
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial.
Moreau P, Hulin C, Perrot A, Arnulf B, Belhadj K, Benboubker L, Béné MC, Zweegman S, Caillon H, Caillot D, Corre J, Delforge M, Dejoie T, Doyen C, Facon T, Sonntag C, Fontan J, Mohty M, Jie KS, Karlin L, Kuhnowski F, Lambert J, Leleu X, Macro M, Orsini-Piocelle F, Roussel M, Stoppa AM, van de Donk NWCJ, Wuillème S, Broijl A, Touzeau C, Tiab M, Marolleau JP, Meuleman N, Vekemans MC, Westerman M, Klein SK, Levin MD, Offner F, Escoffre-Barbe M, Eveillard JR, Garidi R, Ahmadi T, Krevvata M, Zhang K, de Boer C, Vara S, Kampfenkel T, Vanquickelberghe V, Vermeulen J, Avet-Loiseau H, Sonneveld P. Moreau P, et al. Lancet Oncol. 2021 Oct;22(10):1378-1390. doi: 10.1016/S1470-2045(21)00428-9. Epub 2021 Sep 13. Lancet Oncol. 2021. PMID: 34529931 Clinical Trial.
The role of thalidomide in dermatology.
Hussain K, Patel P, Roberts N. Hussain K, et al. Clin Exp Dermatol. 2022 Apr;47(4):667-674. doi: 10.1111/ced.15019. Epub 2021 Dec 19. Clin Exp Dermatol. 2022. PMID: 34779533 Review.
Aponermin: First Approval.
Dhillon S. Dhillon S. Drugs. 2024 Apr;84(4):459-466. doi: 10.1007/s40265-024-02004-9. Drugs. 2024. PMID: 38441805 Review.
2,095 results